Profile data is unavailable for this security.
About the company
Sunshine Guojian Pharmaceutical Shanghai Co Ltd is a China-based company mainly engaged in the research and development, industrialization and commercialization of antibody drugs. Its products are mainly used to treat major diseases such as autoimmune diseases and tumors. The Company’s product, recombinant human type II tumor necrosis factor receptor-antibody fusion protein (trade name: YISAIPU), is a fully human antibody drug used to treat rheumatoid arthritis, ankylosing spondylitis and psoriasis. The Company mainly conducts its businesses in Mainland China.
- Revenue in CNY (TTM)1.22bn
- Net income in CNY363.75m
- Incorporated2002
- Employees965.00
- LocationSunshine Guojian Pharmaceutical Shanghai Co LtdChina (Shanghai) Pilot Free Trade ZoneSHANGHAI 201203ChinaCHN
- Phone+86 2 180297676
- Fax+86 2 180297676
- Websitehttps://www.3s-guojian.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BrightGene Bio-Medical Technology Co Ltd | 1.24bn | 188.08m | 12.70bn | 1.16k | 67.31 | 5.39 | -- | 10.23 | 0.4466 | 0.4466 | 2.96 | 5.57 | 0.2522 | 1.63 | 3.50 | 1,074,862.00 | 2.91 | 6.53 | 3.57 | 7.93 | 54.97 | 56.93 | 11.55 | 19.90 | 1.18 | 4.53 | 0.4841 | 29.31 | 15.94 | 23.68 | -15.51 | 22.56 | 29.13 | -- |
| Jiang Zhong Pharmaceutical Co Ltd | 4.22bn | 753.16m | 13.24bn | 4.01k | 17.55 | 3.56 | -- | 3.14 | 1.20 | 1.20 | 6.71 | 5.91 | 0.6828 | 3.58 | 15.12 | 1,052,061.00 | 13.36 | 10.82 | 20.72 | 15.08 | 63.72 | 65.02 | 19.56 | 18.17 | 0.8833 | -- | 0.0004 | 82.88 | 13.00 | 20.12 | 18.40 | 8.54 | 11.47 | 40.99 |
| Chongqing Taiji Industry Group Co Ltd | 13.87bn | 609.10m | 14.31bn | 12.59k | 23.50 | 3.58 | -- | 1.03 | 1.09 | 1.09 | 24.91 | 7.18 | 0.9696 | 2.82 | 5.08 | 1,102,051.00 | 4.46 | 0.7814 | 12.44 | 2.35 | 42.31 | 44.03 | 4.60 | 0.8498 | 0.4665 | 5.50 | 0.5528 | 25.76 | 10.58 | 7.88 | 131.99 | 63.55 | 3.86 | 24.57 |
| Sunshine Guojian Pharmcutcl Shngh Co Ltd | 1.22bn | 363.75m | 14.49bn | 965.00 | 39.85 | 2.86 | -- | 11.85 | 0.5897 | 0.5897 | 1.98 | 8.23 | 0.2214 | 1.54 | 6.63 | 1,267,186.00 | 6.36 | 1.32 | 6.97 | 1.41 | 75.73 | 80.74 | 28.72 | 6.55 | 3.24 | -- | 0.0098 | 8.25 | 22.84 | -2.35 | 497.63 | -4.44 | 21.22 | -- |
| Zhejiang Jiuzhou Pharmaceutical Co Ltd | 4.91bn | 697.36m | 14.70bn | 4.88k | 21.09 | 1.72 | -- | 2.99 | 0.7749 | 0.7749 | 5.45 | 9.51 | 0.4405 | 1.75 | 4.20 | 1,007,191.00 | 6.28 | 10.10 | 7.67 | 13.69 | 32.61 | 34.64 | 14.25 | 16.26 | 2.48 | -- | 0.0909 | 40.79 | 1.44 | 24.29 | 12.20 | 45.74 | 32.14 | 20.11 |
| Zhejiang Medicine Co., Ltd. | 9.03bn | 977.95m | 15.86bn | 6.23k | 16.12 | 1.53 | -- | 1.76 | 1.02 | 1.02 | 9.54 | 10.75 | 0.694 | 2.94 | 6.01 | 1,450,206.00 | 6.57 | 4.32 | 8.36 | 5.68 | 36.63 | 36.57 | 9.46 | 6.28 | 1.78 | 26.62 | 0.0684 | 58.72 | -3.96 | 2.59 | -20.37 | 3.34 | 12.65 | 0.00 |
| Shanghai Shyndec Pharmaceutical Co Ltd | 11.50bn | 1.08bn | 16.23bn | 11.61k | 14.99 | 1.24 | -- | 1.41 | 0.8071 | 0.8071 | 8.58 | 9.75 | 0.588 | 3.11 | 7.16 | 990,814.20 | 6.99 | 4.85 | 10.16 | 8.17 | 37.73 | 43.00 | 11.88 | 7.03 | 2.03 | -- | 0.1012 | 17.52 | -6.86 | 1.29 | 10.21 | -0.3897 | -2.21 | 0.00 |
| Suzhou Zelgen Biopharmaceuticals Co Ltd | 488.45m | -174.40m | 16.36bn | 867.00 | -- | 12.56 | -- | 33.50 | -0.6692 | -0.6692 | 1.86 | 4.92 | 0.1677 | 0.2615 | 4.39 | 563,380.80 | -6.54 | -27.13 | -11.06 | -39.20 | 92.64 | 92.75 | -39.00 | -220.71 | 1.83 | -- | 0.4159 | -- | 27.83 | 211.81 | 39.08 | -- | 41.38 | -- |
Data as of Nov 01 2024. Currency figures normalised to Sunshine Guojian Pharmaceutical Shanghai Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
3.87%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 7.28m | 1.18% |
| Fullgoal Fund Management Co., Ltd.as of 30 Sep 2023 | 2.68m | 0.43% |
| Bank of China Investment Management Co., Ltd.as of 30 Jun 2024 | 2.57m | 0.42% |
| Ping An Fund Management Co., Ltd.as of 30 Jun 2024 | 2.39m | 0.39% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Sep 2023 | 2.14m | 0.35% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 1.97m | 0.32% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2024 | 1.42m | 0.23% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 1.40m | 0.23% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 1.15m | 0.19% |
| AXA-SPDB Investment Managers Co., Ltd.as of 30 Sep 2023 | 865.06k | 0.14% |
More ▼
Data from 30 Jun 2024 - 23 Oct 2024Source: FactSet Research Systems Inc.
